DHG Pharmaceutical JSC (DHG) — Cash Flow Reinvestment Rate
DHG Pharmaceutical JSC (DHG) has a Cash Flow Reinvestment Rate of 0.20x as of June 2026, reinvesting ₫42.28 Billion (capex ₫42.28 Billion ) from operating cash flow of ₫214.23 Billion. See free cash flow generation of DHG Pharmaceutical JSC to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DHG Pharmaceutical JSC Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for DHG Pharmaceutical JSC across 7 annual periods. For the full cash flow conversion analysis, see DHG cash generation efficiency.
Annual Cash Flow Reinvestment Rate for DHG Pharmaceutical JSC (2019–2025)
Year-by-year capital reinvestment analysis for DHG Pharmaceutical JSC. See DHG Pharmaceutical JSC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | ₫31.14 Billion | ₫1.21 Trillion | ₫31.14 Billion | ▼ -93.7% |
| 2024 | 0.41x | ₫534.66 Billion | ₫1.32 Trillion | ₫88.70 Billion | ▼ -88.1% |
| 2023 | 3.42x | ₫957.17 Billion | ₫279.88 Billion | ₫432.73 Billion | ▲ +1199.5% |
| 2022 | 0.26x | ₫237.20 Billion | ₫901.28 Billion | ₫233.99 Billion | ▲ +383.1% |
| 2021 | 0.05x | ₫24.65 Billion | ₫452.44 Billion | ₫24.56 Billion | ▼ -53.8% |
| 2020 | 0.12x | ₫97.43 Billion | ₫826.17 Billion | ₫88.81 Billion | ▲ +50.4% |
| 2019 | 0.08x | ₫65.73 Billion | ₫838.24 Billion | ₫57.10 Billion | — |